Lonza News and Activities

Presence

Lonza provides manufacturing and development services for the pharmaceutical, biotechnology, and nutrition sectors. Its main offerings include drug ingredients, biologics production, cell and gene therapy support, and capsule products for healthcare customers.

Lonza products and services overview:

Drug development
Biologics manufacturing
Cell therapy
Gene therapy
Capsule products
Nutritional ingredients

Revenue: ~$7 billion

Employees: 17,500

Headquarters: Basel, Switzerland

Lonza is one of the...

Lonza is a company listed under the stock ticker LONN (CH).

Lonza has a direct presence in 3 countries.

Lonza has 3 subsidiaries including Capsugel, Lonza America and Synaffix.

They are in:

Biotechnology50%
Pharmaceuticals50%

Executives

View the org chart displaying its 51 main executives

Most searched biographies at Lonza

Popular executive movements at Lonza

Hans Trees will join the company as Senior Vice President, Global Head of Communications on Sep. 1, 2026 (posted on June 10 2026).
Matthew Moorcroft, who was Senior Vice President, Global Marketing and Intelligence, is promoted to Chief Intelligence and Analytics Officer (posted on June 2 2026).
Claudia Süssmuth Dyckerhoff has joined the company as Director (posted on May 8 2026).

Click here to view some more movements at Lonza

Create your alert
to follow the executive moves at Lonza.